Abstract:Enzyme-linked immune absorbent spot (Elispot) is a quantitative method for measuring relevant parameters of T-cell activation. The sensitivity of Elispot allows the detection of low-frequency antigen-specific T-cells that secrete cytokines and effector molecules, such as granzyme B and perforin. Cytotoxic T-cell (CTL) studies have taken advantage with this high-throughput technology by providing insights of quantity and immune kinetics. Accuracy, sensitivity, reproducibility, and robustness of Elispot resulted in a wide range of applications in research as well as in diagnostic field. Actually, CTL monitoring by Elispot is a gold standard for the evaluation of antigen-specific T-cell immunity in clinical trials and vaccine candidates where the ability to detect rare antigen-specific T-cells is of relevance for immune diagnostic. The most utilized Elispot assay is the Interferon-gamma (IFN-γ) test, a marker for CD8+ CTL activation, but Elispot can be also used to distinguish different subsets of activated T-cells by using other cytokines such as T-helper (Th) 1 type cells (characterized by the production of IFN-γ, IL-2, IL-6, IL-12, IL-21 and TNF-α), Th2 (producing cytokines like IL-4, IL-5, IL-10 and IL-13), and Th17 (IL-17) cells.The reliability of Elispot generated data, by the evaluation of T-cell frequency recognizing individual antigen/peptide, is the core of this method currently applied widely to investigate specific immune responses in cancer, infections, allergies, and autoimmune diseases. The Elispot Assay is competing with other methods measuring single-cell cytokine production, e.g., intracellular cytokine by FACS or Milteny cytokine secretion assay. Other types of lymphocyte frequency and function assays include limiting dilution assay (LDA), cytotoxic T-cell assay (CTL), and tetramer staining. Compared with respect to sensitivity the Elispot Assay is outranking other methods to define frequency of antigen-specific lymphocytes. The method described herein would like to offer helpful and clear protocols for researchers that apply Elispot. IFN-γ and Perforin Elispot assays will be described.

Research Advance and Clinical Application of ELISpot Assay

The development, standardization and application of ELISpot assay

The Detection of Cytotoxic T Lymphocyte about its Activity and its Application

CTL ELISPOT Assay and T Cell Detection

The Applications of ELISpot in the Identification and Treatment of Various Forms of Tuberculosis and in the Cancer Immunotherapies

Enumeration and Characterization of Human Memory T Cells by Enzyme-Linked Immunospot Assays

Use of ELISpot Assay to Study HBs-specific B Cell Responses in Vaccinated and HBV Infected Humans

Basic Research And Clinical Application Of Immune Repertoire Sequencing

Technical op timization for detecting the antigen specific CTL immune response in ELISPOT assay

Progress in Enzyme-linked Immunosorbent Assay

Development of an ELISpot Assay for the Assessment of AAV Peptides to Examine Immune Safety

Routine evaluation of HBV-specific T cell reactivity in chronic hepatitis B using a broad-spectrum T-cell epitope peptide library and ELISpot assay

The co-stimulation of anti-CD28 and IL-2 enhances the sensitivity of ELISPOT assays for detection of neoantigen-specific T cells in PBMC

Frequency and reactivity of antigen-specific T cells were concurrently measured through the combination of artificial antigen-presenting cell, MACS and ELISPOT

A Multiple-Target Simultaneous Detection Method for Immunosorbent Assay and Immunospot Assay

ACE configurator for ELISpot: optimizing combinatorial design of pooled ELISpot assays with an epitope similarity model

Clinical Application of T-SPOT.TB in Diagnosis of HIV/AIDS and TB Patients

Enzyme-linked ImmunoSpot (ELISpot) assay to quantify peptide-specific IFN-γ production by splenocytes in a mouse tumor model after radiation therapy

Advances in the Study of Screening Antigen Dominant Epitopes

Exploring the Usage of ELISPOT As a Diagnostic Method for TB

A New Method of Tuberculosis Infection Diagnosis—Enzyme-Linked Immunospot Assay